AIM ImmunoTech Inc.
AIM
$9.21
$0.9110.96%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.31% | 52.55% | 52.66% | 62.60% | -58.89% |
| Total Depreciation and Amortization | 0.00% | 10.34% | 18.87% | -23.75% | 23.40% |
| Total Amortization of Deferred Charges | -12.33% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 311.43% | -31.56% | 13.21% | 588.37% | 130.97% |
| Change in Net Operating Assets | 3.13% | -32.04% | -80.08% | -179.85% | 180.59% |
| Cash from Operations | 50.97% | 59.47% | 45.16% | -39.39% | -30.84% |
| Capital Expenditure | -- | -100.00% | -80.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 668.35% | 1,466.79% | 220.96% | 493.33% | -47.66% |
| Cash from Investing | 668.35% | 1,830.84% | 199.40% | 504.90% | -102.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.61% | -78.23% | -98.28% | 10,440.00% | 229.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -76.67% | 605.44% | -41.20% | 48,720.00% | 2,729.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.55% | 108.00% | 54.30% | 110.99% | 41.39% |